Transaction in Own Shares

Summary by AI BETAClose X

GSK plc announced on 05 November 2025 that it purchased 175,000 of its ordinary shares of 31¼ pence each on 04 November 2025, as part of its existing buyback programme. The shares were acquired through BNP Paribas SA at prices ranging from 1,747.00p to 1,790.00p, with a volume-weighted average price of 1,768.39p, and will be held as Treasury shares. This transaction brings the total shares purchased since 30 September 2025 to 7,649,000. Following this, GSK now holds 255,113,844 ordinary shares in treasury, representing 6.28% of voting rights, with 4,060,309,755 ordinary shares remaining in issue. This ongoing buyback activity reduces the number of outstanding shares, which can positively impact earnings per share and shareholder value.

Disclaimer*

Companies

GSK (GSK)
UK 100

Latest directors dealings